2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | 1971 | 1970 | 1969 | 1968 | 1967 | 1966 | 1965 | 1964 | 1963 | 1962 | 1961 | 500 | 76 | 0
Synthesis and Characterization of Benzothiophene-3-carbonitrile Derivative and Its Interactions with Human Serum Albumin (HSA)
Authors: Parveen, Mehtab; Aslam, Afroz; Alam, Mahboob; Siddiqui, Mohd Faizan; Bano, Bilqees; Azaz, Shaista; Silva, Manuela Ramos; Pereira Silva, P. S.
Ref.: ChemistrySelect 4, 11979-11986 (2019)
Abstract: A series of biologically active compounds, i. e., benzothiophene-3-carbonitrile derivatives, were synthesized from 1,3-cyclohexanediones and malononitrile in the presence of base using the well-known Gewald reaction. This recyclable approach resulted in significant improvement in overall yield (85-90%), high purity and minimized production of chemical waste without using toxic reagents. The formation of compound, 2-amino-7-oxo-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile (3 a) was additionally supported by X-ray crystallography and was found to crystallize in P2(1)/n space group. The mode of binding of 3 a with human serum albumin (HSA) was studied by FTIR, UV spectroscopy, fluorescence spectroscopy, circular dichroism (CD) and molecular docking studies. The fluorescence results establish that compound 3 a interacted with HSA via static quenching mechanism with a binding affinity of 11.49 x 10(-4) mol(-1) and Gibbs free energy change (Delta G) of-6.8 kcal mol(-1). Molecular docking has been used to calculate the probable mode of interaction of compound 3 a with HSA.
